L

Lifelight

www.lifelight.ai link_icon

Lifelight Company Market Research Report



Company Overview



  • Name: Lifelight, owned by xim Limited.

  • Mission: To deliver personal healthcare monitoring for all at fingertips through contactless vital signs technology.

  • Founded: Developed over 5 years by xim Ltd, with a foundation in healthcare innovations.

  • Founder & Key People:

  • Laurence Pearce, CEO & Founder

  • Gil Baldwin, Non-Executive Chairman

  • Andy Scarlett, Non-Executive Director

  • Headquarters: The University of Southampton Science Park, 2 Venture Road, Chilworth, Southampton, Hampshire SO16 7NP.

  • Number of Employees: Over 40.

  • Revenue: No information is available.

  • Known For: The world’s first clinical-grade contactless technology that estimates vital signs such as blood pressure, pulse, and respiration using a mobile device camera.


Products



Lifelight


  • Description: A medical-grade, contactless health monitoring solution that provides vital sign estimates from mobile devices.

  • Key Features:

  • Completely Contactless: Uses camera built-in on mobile devices to estimate health metrics.

  • Measurements: Blood Pressure, Heart Rate/Pulse, Respiration, and potential future inclusion of Atrial Fibrillation.

  • Speed: Takes readings in 40 seconds.

  • Integration & Compatibility: Available via SDK to integrate into platforms, compatible with various validated mobile devices.

  • Medical Certification: CE and UKCA Class I Medical Device, with future expectation of CE Class IIa conformity.


Recent Developments



  • New Products & Features:

  • Continuously working towards CE Class II medical device certification and gaining FDA clearance.


  • Partnerships:

  • Partnered with Sanitas, a Swiss health insurer, to integrate vital sign readings into their customer app.

  • Collaborated with multiple telehealth organizations across various geographies, including Denmark's Novo Nordisk.


  • Exhibitions & Recognition:

  • Exhibited at Global Health Exhibition in Riyadh and recognized by ORCHA with a top assessment score.

  • Won Science & Tech Company of the Year, showcasing prominence in its field.


  • Funding and Financial Milestones:

  • Successfully raised over $8 million to date, utilizing funds to expand its technology reach globally.


  • Inclusion on Platforms:

  • Appointed to the NHSX Remote Monitoring Technology Platform.

  • Continues clinical trials supported by Portsmouth Hospitals University NHS Trust and Barts Health NHS Trust.


  • COVID-19 Impact and Response:

  • Adapted to play a critical role during the pandemic by allowing remote, zero-contact monitoring of patients' vital signs.


By leveraging its innovative technology, Lifelight aims to revolutionize healthcare monitoring globally, offering contactless, scalable solutions across a range of health and telehealth platforms.